ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: TH-PO1092

Role of Pyruvate Kinase M2-Mediated Metabolic Reprogramming During Podocyte Differentiation

Session Information

Category: Glomerular Diseases

  • 1204 Podocyte Biology

Authors

  • Sun, Qi, Second Affiliated Hospital, Nanjing Medical University, Nanjing, JIANGSU , China
  • Yang, Junwei, Second Affiliated Hospital, Nanjing Medical University, Nanjing, JIANGSU , China
Background

Podocyte, a type of highly specialized epithelial cells with sophisticated foot processes and unique slit diaphragm, requires substantial levels of energy to maintain its integrity and function, but little is known on the regulation of podocyte's energetics. Lack of metabolic analysis during podocyte development led us to explore the role of cellular metabolism and mitochondrial biology during in vitro differentiation.

Methods

To study the metabolic alterations caused by differentiation, nuclear magnetic resonance (NMR) spectroscopy was performed to analyze the metabolomic profiling of differentiated and un-differentiated cultured mouse podocytes. Cell metabolism was measured by seahorse XF analyzer. Mitotracker Red CMXRos and MitoProbe JC-1 Assay Kit were used to identify mitochondrial morphology, mass and membrane potential. Pkm2-RNAi-Lentivirus was used to explore the regulating role of PKM2 during podocyte differentiation.

Results

In this study, we observed a huge increase in mitochondrial biogenesis. Changes in mitochondrial mass, morphology and function were correlated with the upregulation of the master regulators of mitochondrial biogenesis, TFAM and PGC-1α. Unexpectedly, concomitant with mitochondrial biogenesis, we observed an increase in glycolysis during podocyte differentiation, which was linked to the overexpression of glycolic enzymes. Among them, PKM2 was of particular interest. The real-time quantitative PCR and PK activity assay kit showed both pyruvate kinase M2 (PKM2) expression and activity were upregulated. Knockdown of Pkm2 showed dramatic reduction of glycolysis and mitochondrial function, resulting in the defects of podocyte differentiation.

Conclusion

Usually, differentiated cells have repressed glycolysis, as they mostly rely on OXPHOS for energy demand. Our findings here first demonstrate that differentiated podocytes boost both glycolysis and mitochondrial metabolism to meet their augmented energy demand. We identified PKM2 as a critical regulator of energy metabolism in podocytes. Selective inhibition of PKM2 indicate existence of metabolic checkpoint that need to be satisfied in order to allow podocyte differentiation.

Funding

  • Government Support - Non-U.S.